Showing results (81-90 of 184) with videos related to
Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology|September 28, 2016
T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 productionAyako Matsuki, Hiroaki Takatori, Sohei Makita, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|October 14, 2024
Choosing the optimal therapy for metastatic renal cell carcinoma: Insights from a real-world comparative studyTakuto Hara, Jun Teishima, Yasuyoshi Okamura, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Indispensable role of Stat5a in Stat6-independent Th2 cell differentiation and allergic airway inflammationHiroaki Takatori, Hiroshi Nakajima, Koichi Hirose, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 8, 2025
Effect of Prophylactic Administration of Foscarnet for HHV-6 Encephalitis in Adult Single Cord Blood TransplantationKotaro Suzuki, Junya Kanda, Tomoki Iemura, et al.The Prostate|December 27, 2024
Rapid and Deep Prostate-Specific Antigen Decline is a Prognostic Marker in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Multi-Intuitional AnalysisKotaro Suzuki, Takuto Hara, Hiromitsu Watanabe, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|September 3, 2025
Robotic vs. Laparoscopic Adrenalectomy: A Comprehensive Comparison of Surgical Outcomes and Influencing Operative TimeYasuyoshi Okamura, Kotaro Suzuki, Yukari Bando, et al.Leukemia Research|December 15, 2015
A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogeneticsSatoshi Nishiwaki, Masafumi Ito, Rie Watarai, et al.International Journal of Clinical Oncology|December 12, 2024
Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombusKotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, et al.International Journal of Clinical Oncology|October 30, 2024
Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in JapanTakuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, et al.CEN Case Reports|February 13, 2026
Kidney transplantation after chronic active Epstein-Barr virus infection remissionYuki Tashiro, Yoji Hyodo, Satoshi Kitamura, et al.Pageof 19